MERGE EFILM ANNOUNCES PARTNERSHIPS WITH FOUR EUROPEAN VALUE ADDED RESELLERS AND DISTRIBUTORS - Resellers and distributors leverage local relationships to address European demand for RIS/PACS solutions

Milwaukee, WI, September 11, 2003 - Merge Technologies Incorporated (NASDAQ: MRGE), d.b.a Merge eFilm, today announced signed agreements with four European companies to resell or distribute Merge eFilm's FUSION RIS/PACS and eFilm Workstation solutions. These full-service healthcare solution firms will increase the availability of Merge eFilm's products and services throughout European healthcare organizations. The healthcare analysts Frost & Sullivan have estimated the European Medical Image Management annual growth to be 25% per year, reaching $704.5 million in 2004. Merge eFilm's FUSION RIS/PACS software and professional services are designed to meet the needs of this growing European market.

"We partner with companies that have a depth of understanding of medical image and information workflow. That level of comprehension optimizes the flexibility of FUSION RIS/PACS and eFilm Workstation to configure the precise solution that is needed for the customer's workflow," said William Stafford, Vice-President of OEM/VAR Sales. "In addition, the quality of service that these partners provide will assure that users will have a positive, supportive and successful transition from paper and film-based operations to enterprise-wide digital image and information workflow."

The new FUSION RIS/PACS value added resellers include Leuag A.G., Stans, Switzerland; DuMed A/S, Herning, Denmark; and Softgate GmbH, Erlangen, Germany. Hospital Services Limited, Dublin, Ireland, will distribute eFilm Workstation.

***

About Merge eFilm
Merge eFilm is a global healthcare software and services company focused on delivering a suite of RIS/PACS software solutions and professional services to hospitals, imaging centers and clinics. For more than sixteen years, Merge eFilm has leveraged its healthcare IT, clinical and engineering experience to increase productivity, reduce costs and improve patient care by efficiently integrating and automating clinical and administrative workflow. For additional information, visit our web site at
www.merge.com.

Press Contact
Attn: Beth Frost-Johnson Merge Healthcare 6737 West Washington St. Suite 2250 Milwaukee, WI 53214		Phone: 1-(414) 977-4254
Email Address: marketing@merge.com
Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.